Hemophilia
📧 Sign up to get email alerts when something new happens for Hemophilia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-02-14FDA Approved: DESMOPRESSIN ACETATE — Original Application (Dr.Reddys' Laboratories Inc)
FDA approved an original application for Desmopressin Acetate from Dr. Reddy's Laboratories Ltd., a generic version of desmopressin acetate.
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A [Phase 3]
Phase 3 clinical trial evaluating SCT800 for prophylaxis in previously treated patients with severe Hemophilia A has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A [Phase 3]
Phase 3 trial update evaluating pharmacokinetics, efficacy, safety, and immunogenicity of Wilate in previously treated paediatric patients w…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII [Phase 3]
Phase 3 trial update evaluating immunogenicity, efficacy, and safety of human-cl rhFVIII in severe Hemophilia A; results posted after comple…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Canadian Hemophilia Prophylaxis Study [Phase 4]
Phase 4 clinical trial update for prophylaxis in severe Hemophilia A; study completed with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: PF-06741086 Multiple Dose Study in Severe Hemophilia [Phase 2]
Phase 2 multiple-dose study of PF-06741086 in severe hemophilia completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A [Phase 3]
Phase 3 clinical study completed evaluating PK, efficacy, and safety of Wilate in patients with severe hemophilia A, with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A [Phase 3]
Phase 3 trial evaluating personalized prophylaxis with human-cl rhFVIII in severe hemophilia A has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A) [Phase 1, Phase 2]
Phase 1/2 study evaluating safety, tolerability, and pharmacokinetics of a single IV dose of rFVIIIFc-VWF-XTEN (BIVV001) in previously treat…
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Patient Reported Outcomes Burdens and Experiences - Phase 2
Phase 2 clinical trial update focusing on patient-reported outcomes, burdens, and experiences in hemophilia.
-
FDA approval · 2019-10-24FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for Desmopressin Acetate, enabling the generic version to be marketed.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients [Phase 3]
Phase 3 trial update on Human cell line-derived recombinant Factor VIII in previously untreated patients with severe Hemophilia A; results p…
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers [Phase 1]
Phase 1 pharmacokinetics and safety study of emicizumab in healthy Chinese volunteers completed.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures [Phase 3]
A Phase 3 clinical trial update for LR769 in congenital hemophilia patients with inhibitors undergoing elective surgery or invasive procedur…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: BAX 855 PK-guided Dosing [Phase 3]
A Phase 3 trial update on PK-guided dosing for BAX 855 in Hemophilia A has completed with results posted in 2019.
-
FDA approval · 2019-08-23FDA Approved: AMINOCAPROIC ACID — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved a generic aminocaproic acid product from Amneal Pharmaceuticals NY LLC under an Original Application (ANDA 212780). This repres…
-
CLINICAL_TRIALS withdrawal · 2019-08-20Clinical Trial Update: Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform [Phase 3]
Phase 3 hemophilia inhibitor trials (INHIBIT platform) were withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. [Phase 3]
A Phase 3 clinical trial evaluating safety and efficacy of recombinant coagulation factor VIII injection in subjects with Hemophilia A.
-
FDA label_change · 2019-07-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Desmopressin acetate by Meitheal Pharmaceuticals, resulting in a label update associated with th…
-
FDA label_change · 2019-07-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Desmopressin Acetate from Sagent Pharmaceuticals, resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting [Phase 4]
Phase 4 trial update assessing safety and efficacy of ReFacto AF in previously untreated Hemophilia A patients in usual care settings; resul…
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Understanding Hemophilia A and B Drug Dosage Administration Patterns
Clinical trial update on dosage administration patterns for Hemophilia A and B; study is terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A. [Phase 3]
Phase 3 trial evaluating SCT800 in previously treated paediatric patients with severe Hemophilia A, assessing safety, efficacy and pharmacok…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study
A Swedish cohort study reports on treatment patterns and outcomes for patients with Hemophilia A or Hemophilia B treated with Benefix or Ref…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: BAX 855 Continuation [Phase 3]
Phase 3 continuation study for BAX 855 in Hemophilia A has completed; results posted in 2019.